Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Stryker Corp (SYK)

Stryker Corp (SYK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Stryker's Q1 2026 Earnings: What to Expect

Valued at a market cap of $131.5 billion, Stryker Corporation (SYK) is a medical technology company that is widely recognized for its market-leading Mako robotic-arm assisted surgery platform and a diverse portfolio that includes joint replacement implants, surgical equipment, and neurovascular intervention tools. The Portage, Michigan-based company is expected to announce its fiscal Q1 earnings for 2026 after the market closes on Thursday, Apr. 30. 

Ahead of this event, analysts expect this healthcare company to report a profit of $2.99 per share, up 5.3% from $2.84 per share in the year-ago quarter. The company has topped Wall Street’s bottom-line estimates in each of...

Fundamentals

See More
  • Market Capitalization, $K 131,486,072
  • Shares Outstanding, K 382,984
  • Annual Sales, $ 25,116 M
  • Annual Income, $ 3,246 M
  • EBIT $ 5,621 M
  • EBITDA $ 6,814 M
  • 60-Month Beta 0.92
  • Price/Sales 5.16
  • Price/Cash Flow 20.03
  • Price/Book 5.77

Options Overview Details

View History
  • Implied Volatility 29.49% (+1.24%)
  • Historical Volatility 23.89%
  • IV Percentile 90%
  • IV Rank 64.62%
  • IV High 36.07% on 04/21/25
  • IV Low 17.47% on 08/12/25
  • Expected Move (DTE 24) 18.11 (5.35%)
  • Put/Call Vol Ratio 0.41
  • Today's Volume 1,281
  • Volume Avg (30-Day) 1,026
  • Put/Call OI Ratio 0.81
  • Today's Open Interest 22,985
  • Open Int (30-Day) 24,782
  • Expected Range 320.24 to 356.45

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $2.99
  • Number of Estimates 11
  • High Estimate $3.18
  • Low Estimate $2.91
  • Prior Year $2.84
  • Growth Rate Est. (year over year) +5.28%

Price Performance

See More
Period Period Low Period High Performance
1-Month
319.32 +5.96%
on 03/31/26
352.80 -4.10%
on 04/14/26
+2.67 (+0.80%)
since 03/20/26
3-Month
319.32 +5.96%
on 03/31/26
389.33 -13.10%
on 03/02/26
-21.27 (-5.91%)
since 01/20/26
52-Week
319.32 +5.96%
on 03/31/26
404.87 -16.43%
on 07/23/25
-8.16 (-2.35%)
since 04/17/25

Most Recent Stories

More News
Stryker's Q1 2026 Earnings: What to Expect

Stryker is ready to release its fiscal first-quarter earnings this month, and analysts project a single-digit profit growth.

XLV : 147.42 (-0.93%)
SYK : 338.34 (-1.45%)
$SPX : 7,109.14 (-0.24%)
JEF : 47.57 (-1.08%)
Berger Montague PC Investigates Stryker Corporation's Board of Directors for Breach of Fiduciary Duty (NYSE: SYK)

PHILADELPHIA , April 16, 2026 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC advises shareholders of Stryker Corporation (NYSE: SYK) ("Stryker" or the "Company") about an...

SYK : 338.34 (-1.45%)
Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio

Portage, Michigan, April 13, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK), a global leader in medical technologies, announced that it has signed a definitive agreement to acquire Amplitude Vascular Systems,...

SYK : 338.34 (-1.45%)
1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds

1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds

CORT : 46.34 (+0.39%)
RPRX : 49.30 (-1.40%)
SYK : 338.34 (-1.45%)
Stryker (SYK): Buy, Sell, or Hold Post Q4 Earnings?

Stryker (SYK): Buy, Sell, or Hold Post Q4 Earnings?

SYK : 338.34 (-1.45%)
Stryker to announce financial results for its first quarter of fiscal year 2026

Portage, Michigan, April 01, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for its first quarter of fiscal year 2026 on Thursday, April 30, 2026.  A press...

SYK : 338.34 (-1.45%)
Stryker names Nick Mead Vice President, Investor Relations

Portage, Michigan, March 31, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today Nick Mead has been appointed Vice President, Investor Relations, effective...

SYK : 338.34 (-1.45%)
2 Large-Cap Stocks with Exciting Potential and 1 Facing Headwinds

2 Large-Cap Stocks with Exciting Potential and 1 Facing Headwinds

SYK : 338.34 (-1.45%)
VRTX : 439.18 (-0.46%)
CB : 329.99 (-0.25%)
Stryker announces Annual Meeting of Shareholders

Portage, Michigan, March 23, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced its 2026 Annual Meeting of Shareholders is scheduled as follows: Wednesday, May 6, 2026 – 12:00 p.m. Eastern Time...

SYK : 338.34 (-1.45%)
1 Oversold Stock Primed to Rebound and 2 We Question

1 Oversold Stock Primed to Rebound and 2 We Question

ARHS : 8.06 (+3.47%)
SYK : 338.34 (-1.45%)
XRX : 1.8500 (+6.94%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic'products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg'products...

See More

Key Turning Points

3rd Resistance Point 350.13
2nd Resistance Point 347.37
1st Resistance Point 342.86
Last Price 338.34
1st Support Level 335.59
2nd Support Level 332.83
3rd Support Level 328.32

See More

52-Week High 404.87
Fibonacci 61.8% 372.19
Fibonacci 50% 362.10
Fibonacci 38.2% 352.00
Last Price 338.34
52-Week Low 319.32

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.